CD8+ T cells in the tumor microenvironment release interferon-gamma (IFN-γ) that binds to the IFN-γ receptor on the surface of tumor cells, and then activates the JAK-STAT1 signaling pathway to increase the sensitivity of tumor cells to ferroptosis[86–87]. Here, IFNG is linked to neoplasm.